Chiefs of big hospitals and reps of regional chemist's networks annually participate in various presentations of new beta medications. But why in this case the state does not incur somewhat some costs of the pharmaceutical company on new drug development and thereby to decrease the patent validity interval. For this objective the http://www beta. Certainly, the prescription company maker of an innovative medical product wants to completely compensate expenses for development.
Competition is made by generics to the brand medications. The worldwide medical professionals have called for more active introduction of generic drugs in the world pharmaceutical beta marketplace for several long years. So, total expenses for medicines increased not only due to the growing costs, but to a higher demand for drugs. Because insurance businesses have paid for drugs in Europe, people appeared to purchase more drugs at drugstores, beta than earlier.